We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-3.38%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$43.6M
AUM Growth
-$446M
(-91%)
Cap. Flow
-$442M
Cap. Flow
% of AUM
-1,013.48%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
580
New
77
Increased
4
Reduced
27
Closed
472
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.24M |
| 2 |
TSMC
TSM
|
+$1.13M |
| 3 |
NuScale Power
SMR
|
+$1.11M |
| 4 |
Trade Desk
TTD
|
+$1.02M |
| 5 |
Microchip Technology
MCHP
|
+$910K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$5.39M |
| 2 |
Accenture
ACN
|
+$5.35M |
| 3 |
CRWV
CoreWeave
CRWV
|
+$4.97M |
| 4 |
Robinhood
HOOD
|
+$4.87M |
| 5 |
Expedia Group
EXPE
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.63% |
| 2 | Healthcare | 13.02% |
| 3 | Communication Services | 12.94% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Capital One
COF
$124B
| – | – |
-10,628
| Closed | -$2.26M |
|
202
Collegium Pharmaceutical
COLL
$1.14B
| – | – |
-7,853
| Closed | -$275K |
|
|
VISN
203
Vistance Networks Inc
VISN
$2.66B
| – | – |
-111,969
| Closed | -$1.73M |
|
204
Campbell Soup
CPB
$6.51B
| – | – |
-15,600
| Closed | -$493K |
|
205
Camden Property Trust
CPT
$11.3B
| – | – |
-3,000
| Closed | -$320K |
|
206
Crane Co
CR
$13.1B
| – | – |
-1,399
| Closed | -$258K |
|
207
California Resources
CRC
$4.75B
| – | – |
-8,122
| Closed | -$432K |
|
208
Crescent Energy
CRGY
$3.72B
| – | – |
-23,388
| Closed | -$209K |
|
209
CRH
CRH
$66.7B
| – | – |
-4,500
| Closed | -$540K |
|
210
Crocs
CROX
$6.69B
| – | – |
-5,396
| Closed | -$451K |
|
211
Criteo
CRTO
$1.03B
| – | – |
-12,400
| Closed | -$280K |
|
212
Cirrus Logic
CRUS
$6.74B
| – | – |
-4,365
| Closed | -$547K |
|
213
Constellium
CSTM
$3.96B
| – | – |
-11,100
| Closed | -$165K |
|
214
Cintas
CTAS
$82.4B
| – | – |
-3,301
| Closed | -$678K |
|
215
Custom Truck One Source
CTOS
$2.47B
| – | – |
-14,900
| Closed | -$95.7K |
|
216
Cognizant
CTSH
$21.5B
| – | – |
-39,100
| Closed | -$2.62M |
|
217
CubeSmart
CUBE
$9.53B
| – | – |
-8,900
| Closed | -$362K |
|
218
CVR Energy
CVI
$3.36B
| – | – |
-5,969
| Closed | -$218K |
|
219
Commault Systems
CVLT
$5.89B
| – | – |
-3,500
| Closed | -$661K |
|
220
Chevron
CVX
$388B
| – | – |
-4,500
| Closed | -$699K |
|
|
CWAN
221
DELISTED
Clearwater Analytics
CWAN
| – | – |
-30,000
| Closed | -$541K |
|
222
Casella Waste Systems
CWST
$5.69B
| – | – |
-2,811
| Closed | -$267K |
|
223
CryoPort
CYRX
$775M
| – | – |
-10,600
| Closed | -$100K |
|
224
Caesars Entertainment
CZR
$6.1B
| – | – |
-13,857
| Closed | -$374K |
|
225
Dominion Energy
D
$62.5B
| – | – |
-5,900
| Closed | -$361K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Bayesian Capital Management held 580 positions worth $43.6M, down 91% from $490M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bayesian Capital Management withdrew a net $442M in Q4 2025, closing 472 positions and reducing 27 holdings. Its most notable exit was Boston Scientific, an estimated $5.39M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Bayesian Capital Management opened a new position in JPMorgan Chase worth $1.29M.
- Bayesian Capital Management's largest Q4 2025 buy was JPMorgan Chase: 4,000 shares worth $1.29M.
- Bayesian Capital Management added most to TSMC in Q4 2025, an estimated $1.13M increase.
- Bayesian Capital Management's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $4.54M.
- Bayesian Capital Management fully exited Boston Scientific in Q4 2025, selling an estimated $5.39M.
- Bayesian Capital Management's ten largest holdings make up 28% of its $43.6M portfolio in Q4 2025.
- Bayesian Capital Management opened 77 new positions and closed 472 in Q4 2025.
- Bayesian Capital Management's portfolio value fell 91% quarter-over-quarter to $43.6M.
Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.